TALLINN - The coronavirus vaccine study being carried out by drug giant AstraZeneca, with whom Estonia among other states has also signed a pre-purchase agreement, has been paused for the purpose of reviewing the risk of a possible side-effect.
The European Commission signed a pre-purchase agreement with AstraZeneca for a coronavirus vaccine on Aug. 27. A phase three study has at present been temporarily put on hold while the company investigates whether a recipient’s "potentially unexplained" illness is a side effect of the shot.
The article you requested can be accessed only by subscribing to the online version of The Baltic Times. If you are already subscribed to The Baltic Times, please authorize yourself.
In case you don't have a subscription yet - please visit our SUBSCRIPTION